The Luxturna treatment, carried out at the Vision Center at the Children’s Hospital Los Angeles (CHLA), replaces the defective gene RPE65 – responsible for producing a protein that makes light receptors work – with a healthy copy made from artificial DNA.
Sign in to continue
Not already a member of the College?
Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.
These are designed to support providers in developing qualifications to meet the GOC’s Education and Training Requirements for therapeutic prescribing contact lens specialisms.